Drugmaker says FDA modifies hold on experimental Ebola drug, potentially clearing way for use

U.S. News & World Report: WASHINGTON (AP) — U.S. health authorities have eased safety restrictions on an experimental drug to treat Ebola, a move that could clear the way for its use in patients infected with the deadly virus.

Canadian drugmaker Tekmira Pharmaceuticals Corp. said the U.S. Food and Drug Administration modified a hold recently placed on the company's drug after safety issues emerged in human testing.

Read article

Share